Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.07. | Circio Expands Laboratory Operations in Stockholm, Sweden | 8 | Contract Pharma | ||
04.07. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 2 | Oslo Børs | ||
30.06. | Circio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration | 3 | Contract Pharma | ||
30.06. | Circio Holding ASA: NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in vivo stage | 8 | Oslo Børs | ||
20.06. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 4 | Oslo Børs | ||
CIRCIO Aktie jetzt für 0€ handeln | |||||
17.06. | Circio Holding ASA - Funding requested under financing commitment from Atlas | 1 | Oslo Børs | ||
17.06. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 1 | Oslo Børs | ||
16.06. | Circio Holding ASA: TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025 | 1 | Oslo Børs | ||
16.06. | CIRCIO: TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025 | 2 | Cision News | ||
06.06. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 10 | Oslo Børs | ||
05.06. | Circio Holding ASA: Minutes from the annual general meeting 2025 | 7 | Cision News | ||
28.05. | Circio presents new and differentiating circVec data and corporate update in live webcast | 2 | Cision News | ||
27.05. | Circio Holding ASA - Updated information to the notice of annual general meeting 2025 - Reverse share split and share capital decrease | 1 | Cision News | ||
22.05. | Circio Holding ASA: Circio invites to R&D and corporate update webcast on 28 May 2025 | 2 | Oslo Børs | ||
22.05. | Circio invites to R&D and corporate update webcast on 28 May 2025 | 1 | Cision News | ||
15.05. | Circio Holding ASA - Notice of annual general meeting 2025 | 1 | Cision News | ||
15.05. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 2 | Oslo Børs | ||
14.05. | Circio Holding ASA: Atlas Holdings for CIRCIO | 2 | Oslo Børs | ||
14.05. | Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025 | 1 | Cision News | ||
13.05. | Circio Holding ASA - Funding requested under financing commitment from Atlas | - | Oslo Børs |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EVOTEC | 7,456 | +0,59 % | Evotec-Aktie mit Kursgewinnen (7,346 €) | Im Plus liegt derzeit der Anteilsschein von Evotec . Das Papier kostete zuletzt 7,35 Euro. Heute hat sich am deutschen Aktienmarkt das Wertpapier von Evotec zwischenzeitlich um 3,41 Prozent verteuert.... ► Artikel lesen | |
MEDIGENE | 0,121 | -8,36 % | PTA-Adhoc: Medigene AG: Ausscheiden des Vorstandsvorsitzenden Dr. Selwyn Ho und Bestellung von Ralph Schäfer als Vorstand | DJ PTA-Adhoc: Medigene AG: Ausscheiden des Vorstandsvorsitzenden Dr. Selwyn Ho und Bestellung von Ralph Schäfer als Vorstand
Veröffentlichung von Insiderinformationen gemäß Artikel 17 MAR
... ► Artikel lesen | |
PAION | 0,020 | -15,83 % | Paion Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
VALNEVA | 2,726 | -0,07 % | Valneva mit Kurssprung - das ist der Grund | Die Aktie von Valneva kann zum Wochenstart kräftig zulegen. Grund für den Kurssprung sind positive Neuigkeiten von der Europäischen Arzneimittelagentur (EMA). Diese hat die im Mai verhängte Restriktion... ► Artikel lesen | |
NOVAVAX | 6,025 | -0,05 % | Novavax Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
INOVIO PHARMACEUTICALS | 1,230 | +1,65 % | INOVIO Pharma Announces Proposed Public Offering | WASHINGTON (dpa-AFX) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof)... ► Artikel lesen | |
BAVARIAN NORDIC | 24,570 | -0,32 % | Bavarian Nordic A/S: Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country | Recurring order from an undisclosed European country to strengthen public preparedness.Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 million... ► Artikel lesen | |
INFLARX | 0,758 | +2,99 % | InflaRx N.V. - 6-K, Report of foreign issuer | ||
VAXART | 0,321 | -15,53 % | OTC Markets Group Welcomes Vaxart, Inc. to OTCQX | NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vaxart, Inc. (OTCQX:... ► Artikel lesen | |
REDHILL BIOPHARMA | 1,930 | -20,25 % | RedHill Biopharma Ltd.: RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer | Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and... ► Artikel lesen | |
CYTODYN | 0,248 | -1,59 % | CytoDyn Inc.: CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab | Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn's ongoing Phase II CRC trial Dr. Benjamin Weinberg to present final results at the ESMO Gastrointestinal... ► Artikel lesen | |
EMERGENT BIOSOLUTIONS | 6,000 | +0,67 % | Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 | ||
TELIX PHARMACEUTICALS | 13,670 | -0,94 % | JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy? | ||
SINOVAC BIOTECH | - | - | Dividendenbekanntmachungen (08.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCIONA SA ES0125220311 - 5,284 EUR BURCKHARDT COMPRESSION HOLDING AG CH0025536027 18 CHF 19,2591 EUR DOLLAR GENERAL CORPORATION US2566771059 0... ► Artikel lesen | |
CYTOMX THERAPEUTICS | 2,106 | +2,63 % | CytomX Therapeutics Inc.: CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA (pembrolizumab) in Patients with Metastatic Melanoma | SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that the... ► Artikel lesen |